SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Epidemiology and Immune Pathogenesis of Viral Sepsis

Lin, G-L; McGinley, JP; Drysdale, SB; Pollard, AJ (2018) Epidemiology and Immune Pathogenesis of Viral Sepsis. FRONTIERS IN IMMUNOLOGY, 9. p. 2147. ISSN 1664-3224 https://doi.org/10.3389/fimmu.2018.02147
SGUL Authors: Drysdale, Simon Bruce

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (760kB) | Preview

Abstract

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis can be caused by a broad range of pathogens; however, bacterial infections represent the majority of sepsis cases. Up to 42% of sepsis presentations are culture negative, suggesting a non-bacterial cause. Despite this, diagnosis of viral sepsis remains very rare. Almost any virus can cause sepsis in vulnerable patients (e.g., neonates, infants, and other immunosuppressed groups). The prevalence of viral sepsis is not known, nor is there enough information to make an accurate estimate. The initial standard of care for all cases of sepsis, even those that are subsequently proven to be culture negative, is the immediate use of broad-spectrum antibiotics. In the absence of definite diagnostic criteria for viral sepsis, or at least to exclude bacterial sepsis, this inevitably leads to unnecessary antimicrobial use, with associated consequences for antimicrobial resistance, effects on the host microbiome and excess healthcare costs. It is important to understand non-bacterial causes of sepsis so that inappropriate treatment can be minimised, and appropriate treatments can be developed to improve outcomes. In this review, we summarise what is known about viral sepsis, its most common causes, and how the immune responses to severe viral infections can contribute to sepsis. We also discuss strategies to improve our understanding of viral sepsis, and ways we can integrate this new information into effective treatment.

Item Type: Article
Additional Information: © 2018 Lin, McGinley, Drysdale and Pollard. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: viral sepsis, epidemiology, immune pathogenesis, herpes simplex virus, human enterovirus, human parechovirus, influenza virus, dengue virus
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: FRONTIERS IN IMMUNOLOGY
ISSN: 1664-3224
Dates:
DateEvent
27 September 2018Published
30 August 2018Accepted
Publisher License: Creative Commons: Attribution 4.0
Web of Science ID: WOS:000445768500002
URI: https://openaccess.sgul.ac.uk/id/eprint/110283
Publisher's version: https://doi.org/10.3389/fimmu.2018.02147

Statistics

Item downloaded times since 23 Oct 2018.

Actions (login required)

Edit Item Edit Item